Epigenomics
17 papers4 directions
Epigenomics is a research venue active from 2011 to 2026 that focuses on the intersection of molecular biology and computational analysis. The publication covers a range of topics related to epigenetic mechanisms, including DNA methylation, RNA sequencing, and transcriptome hallmarks. Its content often explores the pathogenesis of various conditions, such as sarcopenia, chronic kidney disease, and several types of cancer, including esophageal, gastric, and prostate cancers.
In the context of machine learning and artificial intelligence, the venue serves as a platform for applying computational models to complex biological datasets. Research published here includes the use of machine learning to assess stemness in pancreatic cancer by screening DNA methylation sites and the application of integrated bioinformatics to validate molecular axes in disease progression. These studies frequently utilize methylome-wide association studies and exosome RNA sequencing to identify biomarkers and potential therapeutic targets.
Prolific contributors to the venue include researchers such as Dongjie Yang, Jian Zhang, Xun Hou, and Yulong He. The venue facilitates the dissemination of findings that link molecular data with clinical outcomes, such as the dynamics of cell-free DNA during treatment or the impact of preterm birth on DNA methylation. By integrating computational approaches with epigenetic research, the venue contributes to the understanding of immune and endocrine system involvement in various pathologies.
Papers by Year
| 2026 | 1 |
| 2025 | 2 |
| 2022 | 1 |
| 2020 | 5 |
| 2019 | 2 |
| 2018 | 2 |
| 2016 | 2 |
| 2015 | 1 |
| 2011 | 1 |
Top Research Directions
Research directions most represented by papers from this venue.
Top Authors
| Author | Papers |
|---|---|
| Anna Goldenberg | 1 |
| Gary D. Bader | 1 |
| Kirsi Hannele Pietiläinen | 1 |
| Sangseon Lee | 1 |
| Yichuan Zhao | 1 |